Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are impairing lung function and contributing to ...

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

The Asthma Society of Ireland has warned that over-use of steroid medication may cause more harm than good. A study has shown ...

BOSTON — In a first-of-its-kind analysis, researchers linked a heightened incidence of asthma and chronic obstructive pulmonary disease (COPD) to more socially and environmentally disadvantaged ...

Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...

Steroid tablets are associated with significant adverse side effects. Short-term use risks sleep disturbance, reflux, ...